Controlled Substances Therapeutic Research Act

The act establishes a state-supervised therapeutic research program under which cannabis and other controlled substances may be used medically by patients undergoing cancer chemotherapy and by patients with glaucoma, and it provides that a substance's placement in Schedule I or II does not bar its use within the program. It creates a review committee to oversee the program, requires participating physicians and patients to be certified (and periodically recertified) by the state board of medical examiners, with oncology credentials required in certain cases, and directs the board to adopt implementing rules and guidelines, including arrangements with federal agencies for the state to obtain cannabis for program use. Those acting within the program are exempted from prosecution, the program must report annually to the governor and the legislature, and penalties apply to violations.

Editorial summary generated from the text of this act. It is not part of the statute — read the sections below for the operative language.